These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22366483)

  • 1. Gemcitabine-releasing polymeric films for covered self-expandable metallic stent in treatment of gastrointestinal cancer.
    Lee JW; Yang SG; Na K
    Int J Pharm; 2012 May; 427(2):276-83. PubMed ID: 22366483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An acetylated polysaccharide-PTFE membrane-covered stent for the delivery of gemcitabine for treatment of gastrointestinal cancer and related stenosis.
    Moon S; Yang SG; Na K
    Biomaterials; 2011 May; 32(14):3603-10. PubMed ID: 21334742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety evaluation of self-expanding metallic biliary stents eluting gemcitabine in a porcine model.
    Chung MJ; Kim H; Kim KS; Park S; Chung JB; Park SW
    J Gastroenterol Hepatol; 2012 Feb; 27(2):261-7. PubMed ID: 21793905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine-based polymer-drug conjugate for enhanced anticancer effect in colon cancer.
    Liang TJ; Zhou ZM; Cao YQ; Ma MZ; Wang XJ; Jing K
    Int J Pharm; 2016 Nov; 513(1-2):564-571. PubMed ID: 27613255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photochemical tissue penetration via photosensitizer for effective drug penetration in a non-vascular tumor.
    Min D; Jeong D; Choi MG; Na K
    Biomaterials; 2015 Jun; 52():484-93. PubMed ID: 25818454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and efficacy evaluation of metallic biliary stents eluting gemcitabine and cisplatin for extrahepatic cholangiocarcinoma.
    Xiao JB; Weng JY; Hu YY; Deng GL; Wan XJ
    World J Gastroenterol; 2020 Aug; 26(31):4589-4606. PubMed ID: 32884219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prototype of biliary drug-eluting stent with photodynamic and chemotherapy using electrospinning.
    Chen MH; Liang PC; Chang KC; Huang JY; Chang YT; Chang FY; Wong JM; Lin FH
    Biomed Eng Online; 2014 Aug; 13():118. PubMed ID: 25138739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine hydrochloride microspheres used for intravesical treatment of superficial bladder cancer: a comprehensive in vitro/ex vivo/in vivo evaluation.
    Karavana SY; Şenyiğit ZA; Çalışkan Ç; Sevin G; Özdemir Dİ; Erzurumlu Y; Şen S; Baloğlu E
    Drug Des Devel Ther; 2018; 12():1959-1975. PubMed ID: 29997433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of metallic stents in patients with unresectable pancreatic cancer receiving gemcitabine.
    Nakai Y; Isayama H; Kawabe T; Tsujino T; Yoshida H; Sasaki T; Tada M; Arizumi T; Yagioka H; Kogure H; Togawa O; Ito Y; Matsubara S; Hirano K; Sasahira N; Omata M
    Pancreas; 2008 Nov; 37(4):405-10. PubMed ID: 18953253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabrication and characterization of gefitinib-releasing polyurethane foam as a coating for drug-eluting stent in the treatment of bronchotracheal cancer.
    Chen W; di Carlo C; Devery D; McGrath DJ; McHugh PE; Kleinsteinberg K; Jockenhoevel S; Hennink WE; Kok RJ
    Int J Pharm; 2018 Sep; 548(2):803-811. PubMed ID: 29031981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.
    Chaudhary AK; Mondal G; Kumar V; Kattel K; Mahato RI
    Cancer Lett; 2017 Aug; 402():1-8. PubMed ID: 28536008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel-eluting nanofiber-covered self-expanding nonvascular stent for palliative chemotherapy of gastrointestinal cancer and its related stenosis.
    Kim SY; Kim M; Kim MK; Lee H; Lee DK; Lee DH; Yang SG
    Biomed Microdevices; 2014 Dec; 16(6):897-904. PubMed ID: 25135441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encapsulation of Gemcitabine on Porphyrin Aluminum Metal-Organic Framework by Mechano-Chemistry, Delayed Drug Release and Cytotoxicity to Pancreatic Cancer PANC-1 Cells.
    Umar S; Samokhvalov A
    Molecules; 2024 Jul; 29(13):. PubMed ID: 38999141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemcitabine-loaded Folic Acid Tagged Liposomes: Improved Pharmacokinetic and Biodistribution Profile.
    Unnam S; Panduragaiah VM; Sidramappa MA; Muddana Eswara BR
    Curr Drug Deliv; 2019; 16(2):111-122. PubMed ID: 30360740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micelle Mixtures for Coadministration of Gemcitabine and GDC-0449 To Treat Pancreatic Cancer.
    Karaca M; Dutta R; Ozsoy Y; Mahato RI
    Mol Pharm; 2016 Jun; 13(6):1822-32. PubMed ID: 26981724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancer.
    Réjiba S; Reddy LH; Bigand C; Parmentier C; Couvreur P; Hajri A
    Nanomedicine; 2011 Dec; 7(6):841-9. PubMed ID: 21419876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic biliary drainage for patients with unresectable pancreatic cancer with obstructive jaundice who are to undergo gemcitabine chemotherapy.
    Takasawa O; Fujita N; Kobayashi G; Noda Y; Ito K; Horaguchi J
    World J Gastroenterol; 2006 Dec; 12(45):7299-303. PubMed ID: 17143944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies.
    Tang Z; Feng W; Yang Y; Wang Q
    Drug Des Devel Ther; 2019; 13():3281-3290. PubMed ID: 31571830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer.
    Cosco D; Bulotta A; Ventura M; Celia C; Calimeri T; Perri G; Paolino D; Costa N; Neri P; Tagliaferri P; Tassone P; Fresta M
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):1009-20. PubMed ID: 19263052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabrication of dopamine conjugated with protein @metal organic framework for targeted drug delivery: A biocompatible pH-Responsive nanocarrier for gemcitabine release on MCF‑7 human breast cancer cells.
    Abd Al-Jabbar S; Atiroğlu V; Hameed RM; Guney Eskiler G; Atiroğlu A; Deveci Ozkan A; Özacar M
    Bioorg Chem; 2022 Jan; 118():105467. PubMed ID: 34781115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.